Poseida Therapeutics, Inc. Additional Paid in Capital
Poseida Therapeutics, Inc. had Additional Paid in Capital of $300.00 thousand as of 2022-02-28, per its 10-Q filed 2024-11-07.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent › Additional Paid in Capital
us-gaap:AdditionalPaidInCapital · last filed 2024-11-07
- 2022-02-28: Additional Paid in Capital $300.00K.
- 2017-07-25: Additional Paid in Capital $300.00K.
| Period end | Additional Paid in Capital |
|---|---|
| 2022-02-28 | $300.00K 10-Q · filed 2024-11-07 |
| 2017-07-25 | $300.00K 10-K · filed 2022-03-10 |